Migraines and Tension Headaches: The Neural Network Connection

The headache starts behind your eye. Or in the base of your skull. Or as a band of pressure squeezing your entire head. It comes before deadlines, after arguments, during stressful weeks, or — cruelly — the moment the stress ends and the weekend begins. Your neurologist prescribes triptans. Your GP suggests stress management. Neither asks the question that matters: what mechanism is generating this signal?

Two Headache Types, One Engine

Tension-type headaches and migraines are clinically distinct but share a structural feature: both are triggered and amplified by stress, and research has documented that chronic stress alters pain-processing systems in the central nervous system^[1].

Tension-type headaches involve sustained contraction of the pericranial muscles (scalp, forehead, neck, jaw) driven by sympathetic nervous system activation. When a pathological neural network fires, the autonomic cascade produces muscle tension as part of the fight-or-flight response. If the network fires chronically, the muscle contraction becomes chronic — producing the characteristic “band-like” pressure that tension headache sufferers describe.

Migraines involve a more complex cascade: cortical spreading depression (a wave of neural depolarization across the cortex), trigeminal nerve activation, meningeal inflammation, and changes in cerebral blood flow. Research has documented that fear-based neural networks produce downstream effects on cerebrovascular regulation through the autonomic nervous system^[2], and that cortisol dysregulation from chronic stress alters the threshold at which migraine cascades are triggered^[3].

The Stress-Headache-Stress Loop

Headaches are not only triggered by stress — they produce stress. A migraine that ruins a workday activates fear networks: fear of the next migraine, fear of missing deadlines, fear of being unreliable, fear of the pain itself. This fear activation raises cortisol, increases sympathetic tone, tightens muscles, and lowers the migraine threshold — making the next headache more likely and more intense.

The anticipatory dimension is particularly destructive. Research on conditioned fear^[4] has documented that the anticipation of a painful stimulus can activate the same neural circuits as the stimulus itself. People who get “weekend migraines” or “vacation headaches” experience the let-down effect: during the week, cortisol suppresses the migraine cascade. When the stress ends and cortisol drops, the suppressed cascade fires. The person paradoxically gets headaches when they should be relaxing.

Why Medication Manages But Does Not Resolve

Triptans abort migraine cascades by constricting cranial blood vessels and reducing trigeminal inflammation. Preventive medications (beta-blockers, anticonvulsants, CGRP antagonists, antidepressants) lower the migraine threshold through various neurochemical mechanisms. Both categories provide meaningful symptom management.

But the structural limitation persists: medication addresses the cascade or the threshold without addressing the neural network that keeps the threshold low. When medication is discontinued, the threshold often returns to its pre-treatment level — because the generator that was maintaining the chronic stress state was never addressed. The person needs the medication indefinitely, not because the headaches are permanent, but because the mechanism that sustains them is still running.

The Psychosomatic Pathway

Research published in Clinical Psychopharmacology and Neuroscience^[2] has documented the communication pathways between the central nervous system and peripheral tissues. For headaches, these pathways are specific: the autonomic nervous system controls cerebrovascular tone (blood vessel dilation and constriction in the brain), the HPA axis regulates cortisol (which modulates the migraine threshold), and pro-inflammatory cytokines from chronic stress sensitize the trigeminal nerve endings in the meninges.

The gut–brain axis is also being studied in migraine. Gut microbes can affect tryptophan metabolism and communicate through immune, metabolic, endocrine, and vagal pathways^[5][6]. Most peripheral serotonin is produced in the gut, but it does not simply cross into the brain; therefore a change in gut serotonin cannot by itself be presented as a demonstrated cause of a lower migraine threshold. The connection is plausible and multi-pathway, but still under study.

The Structural Approach

The Efremov Method® approaches chronic headaches by targeting the pathological neural network that maintains the nervous system in a state of chronic activation. When the fear network’s charge is collapsed, sympathetic tone normalizes, cortisol regulation improves, muscle tension decreases, and the migraine threshold rises — because the mechanism that was keeping it artificially low has been structurally removed.

This does not eliminate all headaches (some are triggered by purely physiological factors — hormonal fluctuations, barometric pressure, dehydration). But it addresses the fear-stress-headache cycle that maintains chronicity, lowers thresholds, and turns occasional headaches into a dominant feature of a person’s life.